The Board of Directors of Esperion Therapeutics, Inc. (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
Learn more about our Board of Directors.
Corporate Governance Documents
|Audit Committee||Compensation Committee||Compliance Committee||Nominating and Governance Committee|
|Jeffrey Berkowitz||Compliance Committee|
|Seth H.Z. Fischer||Compliance Committee||Nominating and Governance Committee|
|Alan Fuhrman||Audit Committee||Compliance Committee|
|Antonio Gotto, Jr., MD, DPhil||Nominating and Governance Committee|
|Mark McGovern, MD, FACC, FACP||Nominating and Governance Committee|
|Jay Shepard||Audit Committee||Compensation Committee|
|Nicole Vitullo||Audit Committee||Compensation Committee|
|Tracy Woody||Compensation Committee|
= Chairperson = Member